Literature DB >> 26236989

Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease.

M Teresa Grande1, Berta Sánchez-Laorden1, Cristina López-Blau1, Cristina A De Frutos1, Agnès Boutet1, Miguel Arévalo2,3, R Grant Rowe4, Stephen J Weiss4, José M López-Novoa2,3, M Angela Nieto1.   

Abstract

Progressive kidney fibrosis contributes greatly to end-stage renal failure, and no specific treatment is available to preserve organ function. During renal fibrosis, myofibroblasts accumulate in the interstitium of the kidney, leading to massive deposition of extracellular matrix and organ dysfunction. The origin of myofibroblasts is manifold, but the contribution of an epithelial-to-mesenchymal transition (EMT) undergone by renal epithelial cells during kidney fibrosis is still debated. We show that the reactivation of Snai1 (encoding snail family zinc finger 1, known as Snail1) in mouse renal epithelial cells is required for the development of fibrosis in the kidney. Damage-mediated Snail1 reactivation induces a partial EMT in tubular epithelial cells that, without directly contributing to the myofibroblast population, relays signals to the interstitium to promote myofibroblast differentiation and fibrogenesis and to sustain inflammation. We also show that Snail1-induced fibrosis can be reversed in vivo and that obstructive nephropathy can be therapeutically ameliorated in mice by targeting Snail1 expression. These results reconcile conflicting data on the role of the EMT in renal fibrosis and provide avenues for the design of novel anti-fibrotic therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26236989     DOI: 10.1038/nm.3901

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  44 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 3.  Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

Authors:  Wilhelm Kriz; Brigitte Kaissling; Michel Le Hir
Journal:  J Clin Invest       Date:  2011-02       Impact factor: 14.808

Review 4.  Renal fibrosis: new insights into the pathogenesis and therapeutics.

Authors:  Youhua Liu
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

Review 5.  Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies.

Authors:  Joel Rosenbloom; Susan V Castro; Sergio A Jimenez
Journal:  Ann Intern Med       Date:  2010-02-02       Impact factor: 25.391

6.  Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages.

Authors:  Dennis Shin-Shian Hsu; Hsiao-Jung Wang; Shyh-Kuan Tai; Chun-Hung Chou; Chia-Hsin Hsieh; Po-Hsien Chiu; Nien-Jung Chen; Muh-Hwa Yang
Journal:  Cancer Cell       Date:  2014-10-13       Impact factor: 31.743

Review 7.  Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.

Authors:  Robert L Chevalier; Michael S Forbes; Barbara A Thornhill
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

Review 8.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

9.  Origin and function of myofibroblasts in kidney fibrosis.

Authors:  Valerie S LeBleu; Gangadhar Taduri; Joyce O'Connell; Yingqi Teng; Vesselina G Cooke; Craig Woda; Hikaru Sugimoto; Raghu Kalluri
Journal:  Nat Med       Date:  2013-06-30       Impact factor: 53.440

10.  Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.

Authors:  Vanesa Esteban; Oscar Lorenzo; Mónica Rupérez; Yusuke Suzuki; Sergio Mezzano; Julia Blanco; Mathias Kretzler; Takeshi Sugaya; Jesús Egido; Marta Ruiz-Ortega
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

View more
  265 in total

1.  A new Twist in kidney fibrosis.

Authors:  Yossi Ovadya; Valery Krizhanovsky
Journal:  Nat Med       Date:  2015-09       Impact factor: 53.440

2.  Erratum: Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease.

Authors:  M Teresa Grande; Berta Sánchez-Laorden; Cristina López-Blau; Cristina A De Frutos; Agnès Boutet; Miguel Arévalo; R Grant Rowe; Stephen J Weiss; José M López-Novoa; M Angela Nieto
Journal:  Nat Med       Date:  2016-02       Impact factor: 53.440

3.  Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.

Authors:  Swayam Prakash Srivastava; Julie E Goodwin; Keizo Kanasaki; Daisuke Koya
Journal:  Br J Pharmacol       Date:  2020-06-22       Impact factor: 8.739

4.  Nucleocytoplasmic Shuttling of the Mechanosensitive Transcription Factors MRTF and YAP /TAZ.

Authors:  Michael Kofler; András Kapus
Journal:  Methods Mol Biol       Date:  2021

5.  Parabiosis and single-cell RNA sequencing reveal a limited contribution of monocytes to myofibroblasts in kidney fibrosis.

Authors:  Rafael Kramann; Flavia Machado; Haojia Wu; Tetsuro Kusaba; Konrad Hoeft; Rebekka K Schneider; Benjamin D Humphreys
Journal:  JCI Insight       Date:  2018-05-03

Review 6.  TGF-β1 Signaling and Tissue Fibrosis.

Authors:  Kevin K Kim; Dean Sheppard; Harold A Chapman
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 7.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

8.  Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via αvβ6 integrin signaling.

Authors:  Haili Zhu; Jinlin Liao; Xianke Zhou; Xue Hong; Dongyan Song; Fan Fan Hou; Youhua Liu; Haiyan Fu
Journal:  Kidney Int       Date:  2020-02-17       Impact factor: 10.612

9.  Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate.

Authors:  Amélie Ménard; Nour Abou Nader; Adrien Levasseur; Guillaume St-Jean; Marie Le Gad- Le Roy; Derek Boerboom; Marie-Odile Benoit-Biancamano; Alexandre Boyer
Journal:  Endocrinology       Date:  2020-05-01       Impact factor: 4.736

10.  Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis.

Authors:  Dong Zhou; Yuan Tian; Ling Sun; Lili Zhou; Liangxiang Xiao; Roderick J Tan; Jianwei Tian; Haiyan Fu; Fan Fan Hou; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2016-09-13       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.